MeSH tree: G04.366.500
A simple blood test can reveal the geographic relationships among healthy cells surrounding a cancerous tumor, researchers at Stanford Medicine and the Mayo Clinic have found. The test is the first noninvasive way to study ...
May 6, 2026
0
11
Researchers at Trinity College Dublin have published a major new review that brings fresh clarity to one of the deadliest forms of cancer—pancreatic cancer—by mapping how the disease operates at every level. The review is ...
May 1, 2026
0
13
Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest moments—revealing how lung cells with cancer-causing mutations recruit accomplices from healthy ...
Apr 22, 2026
0
9
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live ...
Apr 14, 2026
0
30
Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and Stanford Medicine suggest that combining targeted radiation therapy with an experimental ...
Mar 27, 2026
0
6
Cancer research laboratory tests can now be done using micro-physiological systems mimicking human physiology, allowing greater predictive accuracy for human patient responses, thanks to an international scientific team led ...
Jan 27, 2026
0
26
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the ...
Jan 22, 2026
0
22
A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric antigen receptor (CAR) T-cell therapy in solid-tumor cancers, resulting in their eradication. Led ...
Dec 12, 2025
0
46
Researchers ushered in a new chapter for personalized and precise cancer diagnostics using technology that can automatically and simultaneously isolate circulating tumor cells (CTC) and circulating cancer-associated fibroblasts ...
Sep 8, 2025
0
17
T-follicular helper (TFH) lymphoma is a blood cancer subgroup that continues to demonstrate a generally poor prognosis, with no standard treatment established to date. Although specific genetic mutations are frequently observed ...
Jun 10, 2025
0
12
